ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,358, issued on Jan. 27, was assigned to Bayer Consumer Care AG (Basel, Switzerland) and Emerald Lake Safety LLC (Newport Beach, Calif.).
"Methods of treatment with elinzanetant" was invented by Michael Block (Basel, Switzerland), Stefan Willmann (Basel, Switzerland), Alexander Solms (Basel, Switzerland), Annika Ruth Patricia Schneider (Basel, Switzerland) and Marcus-Hillert Schultze-Mosgau (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods of treating vasomotor symptoms in a female subject in need thereof by administering a therapeutically effective amount of elinzanetant or a pharmaceuticall...